Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.31 - $5.2 $3,157 - $52,956
-10,184 Reduced 47.65%
11,189 $33,000
Q3 2023

Nov 13, 2023

SELL
$0.37 - $2.85 $10,596 - $81,624
-28,640 Reduced 57.27%
21,373 $9,000
Q2 2023

Aug 10, 2023

BUY
$1.52 - $2.8 $4,818 - $8,876
3,170 Added 6.77%
50,013 $133,000
Q1 2023

May 12, 2023

SELL
$1.87 - $2.54 $1,870 - $2,540
-1,000 Reduced 2.09%
46,843 $91,000
Q4 2022

Feb 10, 2023

SELL
$1.61 - $32.1 $8,050 - $160,500
-5,000 Reduced 9.46%
47,843 $99,000
Q3 2022

Nov 14, 2022

BUY
$0.24 - $30.3 $5,040 - $636,300
21,000 Added 65.95%
52,843 $103,000
Q2 2022

Aug 10, 2022

SELL
$17.7 - $32.55 $46,816 - $86,094
-2,645 Reduced 7.67%
31,843 $46,000
Q1 2022

May 04, 2022

SELL
$21.3 - $39.0 $101,579 - $185,991
-4,769 Reduced 12.15%
34,488 $71,000
Q3 2021

Nov 05, 2021

SELL
$42.6 - $58.65 $153,871 - $211,843
-3,612 Reduced 8.43%
39,257 $124,000
Q2 2021

Aug 02, 2021

SELL
$48.9 - $74.85 $70,024 - $107,185
-1,432 Reduced 3.23%
42,869 $170,000
Q1 2021

May 13, 2021

BUY
$51.3 - $78.15 $38,475 - $58,612
750 Added 1.72%
44,301 $192,000
Q4 2020

Feb 10, 2021

SELL
$28.8 - $100.5 $1.27 Million - $4.44 Million
-44,143 Reduced 50.34%
43,551 $150,000
Q3 2020

Nov 12, 2020

BUY
$30.75 - $42.0 $82,779 - $113,064
2,692 Added 3.17%
87,694 $199,000
Q2 2020

Aug 14, 2020

SELL
$31.8 - $77.64 $225,175 - $549,768
-7,081 Reduced 7.69%
85,002 $204,000
Q1 2020

May 18, 2020

BUY
$33.0 - $85.2 $3.04 Million - $7.85 Million
92,083 New
92,083 $313,000

About BioCardia, Inc.


  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $41.2M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.